Navigation Links
European Small-Joint Reconstructive Implant Market to Nearly Double to $360 Million By 2014

WALTHAM, Mass., Nov. 4 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million. MRG's European Markets for Small-Joint Reconstructive Implants 2009 report finds that as new product designs emerge and device manufacturers focus more aggressively on sales and marketing, public awareness of the treatments and products available will improve, which in turn will prompt more patients to consult their physicians and ultimately undergo small-joint reconstructive procedures.

In recent years, the European market for reconstructive hip and knee implants has grown rapidly and is now maturing. Manufacturers will increasingly focus on the small-joint reconstructive implant market in order to continue to boost their revenues. For example, companies will design and produce new implants such as modular shoulder implants and reverse fracture implants. Because a relatively small number of products were available in this market in 2009, the release of novel implant technologies will support market expansion over the next five years.

"New product launches will be accompanied by greater sales and marketing activity, along with increased surgeon training," says Melissa Hussey, Analyst at MRG. "As a result, awareness will rise among potential patients, and more surgeons will gain proficiency in performing the procedures, increasing the accessibility of these treatments for patients. These marketing initiatives will drive demand and therefore market expansion through 2014."

MRG's new report, European Markets for Small-Joint Reconstructive Implants 2009, provides critical insight into emerging trends that will fuel product adoption and market growth for shoulder, elbow, wrist, ankle, and digit reconstructive implants through 2014 in France, Germany, Italy, and the UK. Additionally, the report provides complete breakdowns of small-joint reconstructive implant procedures, average selling prices, and revenues by device type. Further detail is provided in the thorough examination of trends in the use of primary total, partial, reverse, revision, and resurfacing shoulder implants, as well as mobile and fixed bearing ankle implants, and total and radial head elbow implants. This report includes five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 ext. 101

    Elizabeth Marshall
    Decision Resources Inc.

SOURCE Millennium Research Group

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):